VisszavonvaFázis nélkül
Parathyroid Allotransplantation in Medically Refractory Hypoparathyroidism
A legfontosabb adatok
- Ki végzi
- University of Alabama at Birmingham
- Hol
- Birmingham (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Visszavonva
- Kezdés
- 2027. júl.
- Várható befejezés
- 2030. jan.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Parathyroid Allotransplant
- A regiszteradat frissítve
- 2026. augusztus 21.
- Miért állt le
- Regulatory challenges
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 15 feltétel megnézéseKevesebb
Ki vehet részt
- Individual diagnosed with hypocalcemia secondary to; Hypoparathyroidism:; Prior anterior cervical neck surgery resulting in hypoparathyroidism; Congenital absence or malformation of parathyroid glands during development; Presence of hypoparathyroidism for at least one year; Failure of medical treatment for hypocalcemia, including need for IV calcium, with negative impact on quality of life and daily function; Age 18-80 years; Lives in the greater Birmingham region for the duration of the trial; Fluent in the English Language; Willing to comply with screening, protocol and all required procedures
Ki nem vehet részt
- Current smoker (smoking cessation must have occurred 3 months prior to enrollment)
- Resources deemed inadequate to support necessary post-transplant care
- Any active malignancy, except non-melanoma skin cancer
- History of significant psychiatric illness
- Allergy, hypersensitivity, or intolerance of expected immunosuppressive agents (i.e. Thymoglobulin®, tacrolimus, etc.)
- Documented history of gross non-adherence to medical therapies
- Significant functional/cognitive impairment without reliable caregiver
- Presence of active documented systemic infection or recent systemic infection within the past 3 months
- Seropositivity for HIV, HBV core antibody or antigen, HCV, HTLV-1
- Psychosocial problems (including alcoholism, drug abuse, documented behavioral disorders)
- History of ischemic cardiomyopathy with ejection fraction <20%, uncontrolled diabetes mellitus (Hgb A1c >10), thrombophilia or other clotting or bleeding disorders, significant heart, liver, kidney or central nervous system disease
- Dependence on nursing home or other long-term care provider
- Severe osteoporosis
- Chemical and/or alcohol dependency or abuse
Helyszínek itt: Egyesült Államok
- University of Alabama at BirminghamBirmingham, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
Options for treatment of severe, refractory hypocalcemia are limited for the thousands of patients in the United States who suffer from hypoparathyroidism. Parathyroid allotransplantation is an emerging treatment that provides hope for these individuals. Currently, this therapy has only been successfully provided by a few centers in the world. In the UAB PATH trial, we propose to become one of the few centers worldwide to successfully achieve parathyroid allotransplantation in transplant-naïve patients.
A vizsgált kezelések
- Parathyroid Allotransplant
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- A regiszteradat frissítve
- 2026. augusztus 21.